• Japanese
  • Korean
  • Chinese
Cover Image

Global Markets for Media, Sera and Reagents in Biotechnology

Abstract

REPORT HIGHLIGHTS

The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.

The reagents market reached $1 billion in 2010 and nearly $1.2 billion in 2011. It is expected to grow to $2 billion by 2016, a CAGR of 11.3%.

The media segment reached $820.7 million in 2010 and $897.4 million in 2011. It is expected to grow to $1.4 billion by 2016, a CAGR of 9.4%.

image1

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction in the media, sera and biotechnology reagents markets as an important tool for the cell culture industry.

This report explores present and future strategies within the media and sera market, including reagents used in biotechnology. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The types of cell cultures and the products from cell culture technology are also presented in this report. The advantages and disadvantages for the use of various types of media are also covered in this report.

A detailed analysis of the cell culture industry structure has been conducted. This includes the biotechnology reagents, media and the sera used. Revenues are broken down by global region. Sales figures are estimated for the five-year period from 2011 through 2016.

Applications for the cell culture industry - media, sera and reagents used in biotechnology - are also discussed in the report, with an emphasis on the usage in the research, production and contract segments. The report also covers significant patents in each segment.

REASONS FOR DOING THIS STUDY

Demand for cell culture products, namely media, sera and reagents, is increasing, with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life sciences industry, has witnessed major development during the past three decades. R&D spending, along with increasing competition, patent expiries, new technologies and an international marketplace are moving the cell culture process in a new direction. As cell culture technologies evolved, a number of disciplines such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering have been successfully incorporated into the cell culture field.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of the different types of media used in light of the new technologies, growing competition and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in the cell culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses the biotechnology, pharmaceutical and medical markets. BCC analyzes each market and its applications by its need for development of new medications through cell culture techniques, the regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data was collected through interviews and correspondence with various analytical, chemical, pharmaceutical and biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of biopharmaceuticals, and pharmaceutical companies through their production, research and contract manufacturing/research lines. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a Master's degree in Pharmaceutical Chemistry and has more than 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit.

Table of Contents

Chapter- 1: INTRODUCTION - Complimentary

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter- 2: EXECUTIVE SUMMARY

  • Table Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, THROUGH 2016
  • Figure Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, 2009-2016

Chapter- 3: OVERVIEW

  • DEFINITIONS
  • HISTORY
  • TYPES OF CELL CULTURES
  • MORPHOLOGY OF CELLS IN CULTURE
  • BASIC SYSTEMS FOR CELL CULTURE
  • CELL LINE, CELL STRAIN AND TRANSFORMED CELL LINES
  • FACTORS AFFECTING CELL CULTURE
  • APPLICATIONS OF CELL CULTURE
  • PROBLEMS DURING CELL CULTURE
  • BASIC REQUIREMENTS OF CELL CULTURE
  • REGULATORY ASPECTS
  • APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS
  • ADMINISTRATIVE ACTIONS: BIOLOGICS
  • LEADING MANUFACTURERS OF MEDIA
  • NEW DEVELOPMENTS
  • NEW DEVELOPMENTS IN APPLICATIONS
  • Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE

Chapter- 4: GLOBAL MARKETS

  • MEDIA
  • SERA
  • REAGENTS

Chapter- 5: U.S. MARKET

  • MEDIA
  • SERA
  • REAGENTS
  • U.S. MARKET LEADERS

Chapter- 6: EUROPEAN MARKET

  • MEDIA
  • SERA
  • REAGENTS
  • EUROPEAN MARKET LEADERS

Chapter- 7: ASIAN MARKET

  • MEDIA
  • SERA
  • REAGENTS
  • ASIAN MARKET LEADERS

Chapter- 8: EMERGING MARKETS/REST OF THE WORLD MARKET

  • MEDIA
  • SERA
  • REAGENTS
  • MARKET LEADERS IN THE EMERGING MARKETS

Chapter- 9: END USERS

  • MARKET SHARE OF APPLICATIONS
  • RESEARCH SEGMENT
  • PRODUCTION SEGMENT
  • CONTRACT SEGMENT
  • OTHERS SEGMENT

Chapter- 10: PATENT ANALYSIS

  • PATENTS BY YEAR
  • PATENTS BY TYPE
  • PATENTS BY COMPANY
  • PATENTS BY COUNTRY
  • PATENTS BY ASSIGNEE
  • Table 132 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011

Chapter- 11: THE CURRENT SITUATION

  • REGIONAL MARKETS
  • TRENDS AND ISSUES IN THE CELL CULTURE MARKET

Chapter- 12: COMPANY PROFILES

  • ADVANCED BIOTECHNOLOGIES INC.
  • AFFYMETRIX
  • AMRESCO LLC
  • ATHENA ENVIRONMENTAL SCIENCES INC.
  • ATLANTA BIOLOGICALS INC.
  • BD BIOSCIENCES
  • BIORECLAMATION INC.
  • BOVOGEN BIOLOGICALS PTY. LTD.
  • CELL APPLICATIONS INC.
  • CELL CULTURE TECHNOLOGIES GMBH
  • CLONTECH LABORATORIES INC.
  • EQUITECH-BIO INC.
  • GEMINI BIO-PRODUCTS
  • GENEX INDIA BIOSCIENCES PVT. LTD.
  • HIMEDIA LABORATORIES
  • INVITROGEN CORP.
  • IRVINE SCIENTIFIC
  • J R SCIENTIFIC INC.
  • LONZA
  • MEDIATECH INC.
  • MEDOX BIOTECH INDIA PVT. LTD.
  • MILLIPORE CORP.
  • MP BIOMEDICALS
  • PAA LABORATORIES
  • PEPROTECH INC.
  • PROMOCELL GMBH
  • QUALITY BIOLOGICAL INC.
  • R&D SYSTEMS
  • ROCHE APPLIED SCIENCES
  • SERA LABORATORIES INTERNATIONAL LTD.
  • SERACARE LIFE SCIENCES INC.
  • SIGMA-ALDRICH
  • STEMCELL TECHNOLOGIES
  • STEMCELLS INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TICO EUROPE
  • VALLEY BIOMEDICAL PRODUCTS AND SERVICES INC.

Chapter- 13: APPENDIX: ABBREVIATIONS

List of Tables

  • Summary Table : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, THROUGH 2016
  • Table 1 : HISTORICAL EVENTS IN CELL CULTURE DEVELOPMENT
  • Table 2 : ADVANTAGES AND DISADVANTAGES OF PRIMARY CELL CULTURE
  • Table 3 : ADVANTAGES AND DISADVANTAGES OF CONTINUOUS CELL CULTURE
  • Table 4 : ADHERENT CULTURE VS. SUSPENSION CULTURE
  • Table 5 : CULTURE MEDIA USED FOR THE PRODUCTION OF VACCINES
  • Table 6 : POTENTIAL SOURCES OF CELL CULTURE ADDITIVES
  • Table 7 : RECOMBINANT THROMBOLYTIC AGENTS
  • Table 8 : RECOMBINANT COAGULATION FACTOR
  • Table 9 : THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
  • Table 10 : COMMONLY USED ANTIBIOTICS IN CELL CULTURES
  • Table 11 : ADVANTAGES AND DISADVANTAGES OF SERUM-CONTAINING MEDIA
  • Table 12 : ADVANTAGES AND DISADVANTAGES OF SERUM-FREE MEDIA
  • Table 13 : NORMAL RANGE OF CONCENTRATION OF SERUM CONSTITUENTS
  • Table 14 : APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS, 2010 TO AUG. 2011
  • Table 15 : ADMINISTRATIVE ACTIONS: BIOLOGICS, 2007 TO AUG. 2011
  • Table 16 : PRODUCT RECALLS, 2007 TO AUG. 2011
  • Table 17 : LEADING MANUFACTURERS OF MEDIA
  • Table 18 : LEADING MANUFACTURERS OF SERA
  • Table 19 : LEADING MANUFACTURERS OF BIOLOGIC RESPONSE MODIFIERS
  • Table 20 : LEADING MANUFACTURERS OF CELL DISSOCIATION REAGENTS
  • Table 21 : LEADING MANUFACTURERS OF ANTIBIOTICS AND ANTIMYCOTICS USED IN CELL CULTURE
  • Table 22 : LEADING MANUFACTURERS OF OTHER REAGENTS
  • Table 23 : NEW DEVELOPMENTS IN THE CELL CULTURE INDUSTRY SINCE 2008
  • Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE
  • Table 25 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 26 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, THROUGH 2016
  • Table 27 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
  • Table 28 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, THROUGH 2016
  • Table 29 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, THROUGH 2016
  • Table 30 : GLOBAL MARKET FOR POWDERED MEDIA, THROUGH 2016
  • Table 31 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, THROUGH 2016
  • Table 32 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, THROUGH 2016
  • Table 33 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, THROUGH 2016
  • Table 34 : GLOBAL MARKET FOR SERA BY REGION, THROUGH 2016
  • Table 35 : GLOBAL SERA MARKET SHARES BY REGION, 2010
  • Table 36 : GLOBAL MARKET FOR BOVINE SERA BY REGION, THROUGH 2016
  • Table 37 : GLOBAL MARKET FOR OTHER SERA BY REGION, THROUGH 2016
  • Table 38 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, THROUGH 2016
  • Table 39 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
  • Table 40 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION, THROUGH 2016
  • Table 41 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, THROUGH 2016
  • Table 42 : GLOBAL MARKET FOR CYTOKINES BY REGION, THROUGH 2016
  • Table 43 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY REGION, THROUGH 2016
  • Table 44 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION, THROUGH 2016
  • Table 45 : GLOBAL MARKET FOR OTHERS BY REGION, THROUGH 2016
  • Table 46 : U.S. MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 47 : U.S. MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
  • Table 48 : U.S. MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Table 49 : U.S. MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Table 50 : U.S. MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Table 51 : U.S. MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Table 52 : U.S. MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Table 53 : U.S. MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
  • Table 54 : U.S. MARKET SHARES OF SERUM-FREE MEDIA, 2010
  • Table 55 : U.S. MARKET SHARES OF SERUM-CONTAINING MEDIA, 2010
  • Table 56 : U.S. MARKET SHARES OF POWDERED MEDIA, 2010
  • Table 57 : U.S. MARKET SHARES OF LIQUID MEDIA, 2010
  • Table 58 : U.S. MARKET SHARES OF CLASSICAL MEDIA, 2010
  • Table 59 : U.S. MARKET SHARES OF SPECIALTY MEDIA, 2010
  • Table 60 : U.S. MARKET SHARES OF BOVINE SERA, 2010
  • Table 61 : U.S. MARKET SHARES OF OTHER SERA, 2010
  • Table 62 : U.S. MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, 2010
  • Table 63 : U.S. MARKET SHARES OF CELL DISSOCIATION REAGENTS, 2010
  • Table 64 : U.S. MARKET SHARES OF OTHER REAGENTS, 2010
  • Table 65 : EUROPEAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 66 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
  • Table 67 : EUROPEAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Table 68 : EUROPEAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Table 69 : EUROPEAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Table 70 : EUROPEAN MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Table 71 : EUROPEAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Table 72 : EUROPEAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
  • Table 73 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
  • Table 74 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
  • Table 75 : EUROPEAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY, 2010
  • Table 76 : EUROPEAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
  • Table 77 : EUROPEAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
  • Table 78 : EUROPEAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
  • Table 79 : EUROPEAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
  • Table 80 : EUROPEAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
  • Table 81 : EUROPEAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY COMPANY, 2010
  • Table 82 : EUROPEAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY, 2010
  • Table 83 : EUROPEAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
  • Table 84 : ASIAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 85 : ASIAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
  • Table 86 : ASIAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Table 87 : ASIAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Table 88 : ASIAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Table 89 : ASIAN MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Table 90 : ASIAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Table 91 : ASIAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
  • Table 92 : ASIAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
  • Table 93 : ASIAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY, 2010
  • Table 94 : ASIAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
  • Table 95 : ASIAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
  • Table 96 : ASIAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
  • Table 97 : ASIAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
  • Table 98 : ASIAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
  • Table 99 : ASIAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
  • Table 100 : ASIAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY COMPANY, 2010
  • Table 101 : ASIAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY, 2010
  • Table 102 : ASIAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
  • Table 103 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 104 : EMERGING MARKETS FOR CELL CULTURE MEDIA, THROUGH 2016
  • Table 105 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Table 106 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Table 107 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Table 108 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Table 109 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Table 110 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
  • Table 111 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 112 : MARKET SHARES OF SERUM-CONTAINING MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 113 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 114 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 115 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 116 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 117 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 118 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 119 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 120 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 121 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 122 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
  • Table 123 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH SEGMENT, THROUGH 2016
  • Table 124 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION SEGMENT, THROUGH 2016
  • Table 125 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT SEGMENT, THROUGH 2016
  • Table 126 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS SEGMENT, THROUGH 2016
  • Table 127 : NUMBER OF U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
  • Table 128 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY, 2007 - 2011
  • Table 129 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY BY COMPANY, 2007 TO OCT. 2011
  • Table 130 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY COUNTRY, 2007 TO OCT. 2011
  • Table 131 : SHARES OF U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY COUNTRY, 2007 - OCT. 2011
  • Table 132 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011
  • Table 133 : R&D BUDGETS OF TOP 10 COMPANIES IN 2009 AND 2010

List of Figures

  • Summary Figure : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, 2009-2016
  • Figure 1 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 2 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, 2009-2016
  • Figure 3 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
  • Figure 4 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, 2009-2016
  • Figure 5 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, 2009-2016
  • Figure 6 : GLOBAL MARKET FOR POWDERED MEDIA, 2009-2016
  • Figure 7 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, 2009-2016
  • Figure 8 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, 2009 - 2016
  • Figure 9 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, 2009-2016
  • Figure 10 : GLOBAL MARKET FOR SERA BY REGION, 2009 - 2016
  • Figure 11 : GLOBAL SERA MARKET SHARES BY REGION, 2010
  • Figure 12 : GLOBAL MARKET FOR BOVINE SERA BY REGION, 2009 - 2016
  • Figure 13 : GLOBAL MARKET FOR OTHER SERA BY REGION, 2009-2016
  • Figure 14 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, 2009-2016
  • Figure 15 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
  • Figure 16 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION, 2009-2016
  • Figure 17 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, 2009- 2016
  • Figure 18 : GLOBAL MARKET FOR CYTOKINES BY REGION, 2009-2016
  • Figure 19 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY REGION, 2009-2016
  • Figure 20 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION, 2009-2016
  • Figure 21 : GLOBAL MARKET FOR OTHERS BY REGION, 2009-2016
  • Figure 22 : U.S. MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 23 : U.S. MARKET FOR CELL CULTURE MEDIA, 2009-2016
  • Figure 24 : U.S. MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, 2009-2016
  • Figure 25 : U.S. MARKET FOR POWDERED AND LIQUID MEDIA, 2009-2016
  • Figure 26 : U.S. MARKET FOR CLASSICAL AND SPECIALTY MEDIA, 2009-2016
  • Figure 27 : U.S. MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Figure 28 : U.S. MARKET FOR CELL CULTURE REAGENTS, 2009-2016
  • Figure 29 : U.S. MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
  • Figure 30 : U.S. MARKET SHARES OF SERUM-FREE MEDIA, 2010
  • Figure 31 : U.S. MARKET SHARES OF SERUM-CONTAINING MEDIA, 2010
  • Figure 32 : U.S. MARKET SHARES OF POWDERED MEDIA, 2010
  • Figure 33 : U.S. MARKET SHARES OF LIQUID MEDIA, 2010
  • Figure 34 : U.S. MARKET SHARES OF CLASSICAL MEDIA, 2010
  • Figure 35 : U.S. MARKET SHARES OF SPECIALTY MEDIA, 2010
  • Figure 36 : U.S. MARKET SHARES OF BOVINE SERA, 2010
  • Figure 37 : U.S. MARKET SHARES OF OTHER SERA, 2010
  • Figure 38 : U.S. MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, 2010
  • Figure 39 : U.S. MARKET SHARES OF CELL DISSOCIATION REAGENTS, 2010
  • Figure 40 : U.S. MARKET SHARES OF OTHER REAGENTS, 2010
  • Figure 41 : EUROPEAN MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 42 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, 2009-2016
  • Figure 43 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, 2009-2016
  • Figure 44 : EUROPEAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Figure 45 : EUROPEAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Figure 46 : EUROPEAN MARKET FOR BOVINE AND OTHER SERA, 2009-2016
  • Figure 47 : EUROPEAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Figure 48 : EUROPEAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
  • Figure 49 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
  • Figure 50 : EUROPEAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY, 2010
  • Figure 51 : EUROPEAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
  • Figure 52 : EUROPEAN MARKET SHARES OF LIQUID MEDIA, 2010
  • Figure 53 : EUROPEAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
  • Figure 54 : EUROPEAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
  • Figure 55 : EUROPEAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
  • Figure 56 : EUROPEAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
  • Figure 57 : EUROPEAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY COMPANY, 2010
  • Figure 58 : EUROPEAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY, 2010
  • Figure 59 : EUROPEAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
  • Figure 60 : ASIAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Figure 61 : ASIAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
  • Figure 62 : ASIAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, 2009-2016
  • Figure 63 : ASIAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Figure 64 : ASIAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Figure 65 : ASIAN MARKET FOR BOVINE AND OTHER SERA, 2009-2016
  • Figure 66 : ASIAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Figure 67 : ASIAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
  • Figure 68 : ASIAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
  • Figure 69 : ASIAN MARKET SHARES OF SERUM CONTAINING MEDIA BY COMPANY, 2010
  • Figure 70 : ASIAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
  • Figure 71 : ASIAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
  • Figure 72 : ASIAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
  • Figure 73 : ASIAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
  • Figure 74 : ASIAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
  • Figure 75 : ASIAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
  • Figure 76 : ASIAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY COMPANY, 2010
  • Figure 77 : ASIAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY, 2010
  • Figure 78 : ASIAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
  • Figure 79 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 80 : EMERGING MARKETS FOR CELL CULTURE MEDIA, 2009-2016
  • Figure 81 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Figure 82 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, 2009-2016
  • Figure 83 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, 2009 2016
  • Figure 84 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, 2009-2016
  • Figure 85 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, 2009-2016
  • Figure 86 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
  • Figure 87 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 88 : MARKET SHARES OF SERUM CONTAINING MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 89 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 90 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 91 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 92 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 93 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 94 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 95 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 96 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 97 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 98 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
  • Figure 99 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH SEGMENT, 2009-2016
  • Figure 100 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION SEGMENT, 2009-2016
  • Figure 101 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT SEGMENT, 2009-2016
  • Figure 102 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS SEGMENT, 2009-2016
  • Figure 103 : U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
  • Figure 104 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY, 2007 - 2011
Show More
Pricing
Get Notified
Email me when related reports are published